Identifying COVID-19 Patients from Unstructured Notes: Performance of a Commercial Clinical Named Entity Recognition System
An OMNY Health™ Poster
Commercial named entity recognition (NER) could be effective in identifying new and emerging illnesses.
On May 17-21, 2021, this poster was presented at the ISPOR Annual Conference.
- The results show that ACM-ICD-10 is effective at identifying symptoms and alternative, nonspecific diagnosis codes for COVID-19.
- However, the current version of the software failed to map any of the patients to the Center for Disease Control’s most recent code recommendation for COVID-19 infection (U07.1).
- The results suggest that such commercial clinical NER tools need to be recalibrated often to account for new and emerging illnesses.
- Limitations of this study include a small sample size from just one medical institution.
Check Out More Events & Webinars…
Reach out to us for more information about OMNY Health, our platform, and our mission.
Sign up for Our Newsletter
Sign up now to receive our newsletter in the future with OMNY Health updates and industry insights.